Chemical Compound
5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-; 5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI); 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineethanethioamide; 2-n-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one; Fimasartan; Kanarb
CAS Registry Number
247257-48-3
Primary record
5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-; 5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI); 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineethanethioamide; 2-n-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one; Fimasartan; Kanarb
- 库存
- 5,937 克
- 纯度
- 99.5 %
- CAS
- 247257-48-3
化合物标识与属性
- CAS
- 247257-48-3
- PubChem CID
- 9870652
- SMILES
- CCCCC1=NC(=C(C(=O)N1CC2=CC=C(C=C2)C3=CC=CC=C3C4=NNN=N4)CC(=S)N(C)C)C
- Canonical SMILES
- CCCCc1nc(C)c(CC(=S)N(C)C)c(=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
名称与同义词
- FIMASARTAN
- 247257-48-3
- Kanarb
- fimasartanum
- Fimasartan [INN]
- Fimasartan?
- fimasartan potassium
- Fimasartan (INN)
- Fimasartan Impurity 1
- FiMasartan Impurity 13
- RefChem:140452
- C27H31N7OS
- fimasartan potassium hydrate
- DTXSID80179460
- FIMASARTAN [WHO-DD]
- MFCD13194795
- CHEMBL1951143
- BR1015 component fimasartan
- BR1019 component fimasartan
- BR-A657
- Fimasartan Potassium Trihydrate
- BR-A-657.K
- orb1305694
- SCHEMBL2229436
- UNII-P58222188P
- SCHEMBL20126833
- SCHEMBL29376979
- SCHEMBL29392281
- CTK8H8115
- C09CA10
- DTXCID10101951
- AMEROGPZOLAFBN-UHFFFAOYSA-N
- CHEBI:136044
- BR-A-657-K
- GLXC-15574
- HMS5084I05
- BCP11616
- BR-A-657
- EX-A3997
- HY-B0780
- KS-00001F8R
- ZINC3842872
- 1904AB
- BDBM50364573
- MFCD24369685
- s4975
- ZB1816
- P58222188P
- AKOS016011331
- AKOS037643761
- CCG-269705
- CID9870652
- CS-3509
- DB09279
- FB75008
- 2-(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide
- CID 9870652
- CID:9870652
- NCGC00390600-01
- AC-30631
- AK120789
- AS-35179
- DA-73369
- SY240806
- SID:375590838
- B4866
- NS00069389
- J3.006.756H
- D10556
- 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethylethanethioamide
- 257F483
- A919293
- C558933
- L019170
- 5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-
- Q8563179
- BRD-K21586122-001-01-9
- B0084-474719
- N0001-011286
- 2-(2-Butyl-4-methyl-6-oxo-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,6-dihydro-5-pyrimidinyl)-N,N-dimethylethanethioamide
- 2-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one
- (2-Butyl-4-methyl-6-oxo-1-{[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide
- 2-((2-BUTYL-4-METHYL-6-OXO-1-((2'-(1H-TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-1,6-DIHYDROPYRIMIDIN-5-YL))-N,N-DIMETHYLTHIOACETAMIDE
- 2-(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide
- 2-(1-((2'-(1H-Tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide
- 2-(1-((2-(2H-Tetrazol-5-yl)-[1,1-biphenyl]-4-yl)methyl)-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide
- 2-(2-Butyl-4-me thyl-6-oxo-1-{[2'-(1H-tetrazol-5-yl)-4-biphenylyl]methyl}-1,6-dihydro-5-pyrimidinyl)-N,N-dimethylethanethioamide
- 2-(2-butyl-4-methyl-6-oxo-1-((2'-(1H-1,2,3,4-tetrazol-5-yl)-(1,1'-biphenyl)-4-yl)methyl)-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide
- 2-(2-butyl-4-methyl-6-oxo-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1,6-dihydropyrimidin-5-yl)-N,N-dimethylethanethioamide
- 2-[1-[[2 inverted exclamation mark -(2H-Tetrazol-5-yl)-[1,1 inverted exclamation mark -biphenyl]-4-yl]methyl]-2-butyl-4-methyl-6-oxo-1,6-dihydropyrimidin-5-yl]-N,N-dimethylethanethioamide
- 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]met hyl]pyrimidin-5-yl]-N,N-dimethylethanethioamide
- 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethyl-thioacetamide
- 2-[2-butyl-4-methyl-6-oxo-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]pyrimidin-5-yl]-N,N-dimethylethanethioamideBR-A657
- 2-Butyl-5-[(dimethylthiocarbamoyl)methyl]-6-methyl-3-[2 -(1H-tetrazole-5-yl)-4-biphenylylmethyl]pyrimidine-4(3H)-one
- 2-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'- biphenyl-4-yl]methyl]pyrimidin-4 -one
- 2-n-butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methyl]-pyrimidine-4(3H)-one
- 5-?Pyrimidineethanethio?amide, 2-?butyl-?1,?6-?dihydro-?N,?N,?4-?trimethyl-?6-?oxo-?1-?[[2'-?(2H-?tetrazol-?5-?yl)?[1,?1'-?biphenyl]?-?4-?yl]?methyl]?-
- 5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-
- 5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-; 5-Pyrimidineethanethioamide, 2-butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI); 2-Butyl-1,6-dihydro-N,N,4-trimethyl-6-oxo-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-5-pyrimidineethanethioamide; 2-n-Butyl-5-dimethylaminothiocarbonylmethyl-6-methyl-3-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]pyrimidin-4(3H)-one; Fimasartan; Kanarb